Bmtcn chapter 1 - Study guides, Class notes & Summaries

BMTCN Chapter 6 Post-Transplant Issues Which of the following is NOT an identified risk factor associated with infection? A. Personal history of infection B. Type of transplantation (autologous or allogeneic) C. Myeloablative transplant D. None of the above - correct answer D. None of the above Clostridium difficile is not a common infection in the post-transplant setting. A. True B. False - correct answer B. False A cord blood transplantation is associated with all of the fo...

BMTCN Chapter 1 Basic Concepts and Indications for Transplantation Question and answers rated A+ 2023/2024Which of the following is an example of a myeloid cell? A. Thymus-derived cells (T cells) B. Bone marrow-derived cells (B cells) C. Monocytes D. Natural killer cells - correct answer C. Monocytes Several factors affect immune reconstitution following hematopoietic stem cell transplantation (HSCT). These include all of the following EXCEPT: A. Recipient's response to conditioning reg...

BMTCN Chapter 6 Post-Transplant Issues Which of the following is NOT an identified risk factor associated with infection? A. Personal history of infection B. Type of transplantation (autologous or allogeneic) C. Myeloablative transplant D. None of the above - correct answer D. None of the above Clostridium difficile is not a common infection in the post-transplant setting. A. True B. False - correct answer B. False A cord blood transplantation is associated with all of the fo...

BMTCN Review Chapter 1-Basic Concepts and Indications for TransplantationGoal of Transplant - correct answer -Cure disease -Increase disease free survival Hematopoiesis - correct answer -Regulation, production and development of blood cells -Pluripotent Stem cells -Progenitor Stem Cells. -Myeloid and lymphoid lineage Myeloid progenitor cells mature into: - correct answer Megakaryocytes (platelets) Erythrocytes Mast cells Myeloblasts Lymphoid progenitor cells mature into: - correc...

BMTCN Chapter 1 red marrow - what does it make, and where? - correct answer produces hematopoietic stem cells that create RBC, WBC, platelets, found in long, flat bones yellow marrow - what does it make, and where? - correct answer produces stromal stem cells for fat, cartilage, nad bone, found in long bones where are hematopoietic cells made in adults vs children? - correct answer long bones in childhood, axial skeleton in adulthood myeloid cells mature into: (4) - correct answer mega...

BMTCN Review Chapter 1-Basic Concepts and Indications for Transplantation Exam 2023/2024

BMTCN - Chapter 5 (chronic GVHD) Questions with complete solution 2023/2024 What is chronic GVHD? - correct answer Late complication of HSCT effecting quality of life, immune mediated disorder. Must have at least one diagnostic manifestation of chronic GVHD or at least one distinctive sign confirmed by lab test. It can involve one or more organs. Failure to improve after at least 2 months or progression after 1 month of standard corticosteroid based immunosuppressive therapy What dif...

BMTCN Chapter 1 Basic Concepts and Indications for Transplantation Which of the following is an example of a myeloid cell? A. Thymus-derived cells (T cells) B. Bone marrow-derived cells (B cells) C. Monocytes D. Natural killer cells - correct answer C. Monocytes Several factors affect immune reconstitution following hematopoietic stem cell transplantation (HSCT). These include all of the following EXCEPT: A. Recipient's response to conditioning regimen B. Viral infections C. Chronic ...

BMTCN - Chapter 6What are the types of cardiac diseases common post HSCT? What conditioning medications can cause these diseases? - correct answer Cardiomyopathy, arrhythmias, congestive heart failure - high dose Cytoxan and radiation causes this HTN/Dyslipidemia: Immunosuppression meds HTN/Hyperkalemia: Cyclosporine HTN/Hyperlipidemia and edema: Sirolimus How would you management cardiac disease in post-HSCT patients? - correct answer Assess risk factors, follow up testing (EKG, ...

BMTCN Chapter 5 Graft-versus-Host DiseaseT.R. is a 28-year-old woman with acute myeloid leukemia in her second complete remission who is admitted for a matched unrelated allogeneic stem cell transplantation. Her conditioning regimen is as follows: Myeloablation (busulfan/cyclophosphamide) and immunosuppression with tacrolimus and methotrexate (5 mg/m2 on days +1, +3, +6, and +11). She did not receive methotrexate on day +11 because of severe mucositis. Her transplant course was complicated...